TYR and melanoma: Patients 10713, 10770, and 10757 failed to generate IFNγ secretion in response to gp100 or MART-1, but were capable of excellent IFNγ secretion in response to viral antigens or a different melanoma antigen, tyrosinase (Figure 7).